Search Results

There are 14024 results for: content related to: C ase R eport : Agranulocytosis induced by interferon-α therapy for chronic hepatitis C

  1. You have free access to this content
    Haematological toxicity of drugs used in psychiatry

    Human Psychopharmacology: Clinical and Experimental

    Volume 23, Issue S1, January 2008, Pages: S27–S41, Robert J. Flanagan and Louisa Dunk

    Version of Record online : 20 DEC 2007, DOI: 10.1002/hup.917

  2. You have full text access to this OnlineOpen article
    Deferiprone-induced agranulocytosis: 20 years of clinical observations

    American Journal of Hematology

    Volume 91, Issue 10, October 2016, Pages: 1026–1031, Fernando Tricta, Jack Uetrecht, Renzo Galanello, John Connelly, Anna Rozova, Michael Spino and Jan Palmblad

    Version of Record online : 4 AUG 2016, DOI: 10.1002/ajh.24479

  3. Nonchemotherapy Drug-Induced Agranulocytosis: A Review of 118 Patients Treated with Colony-Stimulating Factors

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 19, Issue 3, March 1999, Pages: 299–305, Dr. Marie-France Beauchesne and Dr. Stephen J. Shalansky

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.19.4.299.30941

  4. METHIMAZOLE-INDUCED AGRANULOCYTOSIS IN JAPANESE PATIENTS WITH GRAVES’ DISEASE

    Clinical Endocrinology

    Volume 30, Issue 5, May 1989, Pages: 525–530, HAJIME TAMAI, YUKIHIKO TAKAICHI, TETSUYA MORITA, GEN KOMAKI, SUNAO MATSUBAYASHI, KANJI KUMA, ROBERT M. WALTER JR., LINDY F. KUMAGAI and SHIGENOBU NAGATAKI

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1365-2265.1989.tb01424.x

  5. Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case–control study

    Pharmacoepidemiology and Drug Safety

    Volume 26, Issue 3, March 2017, Pages: 248–255, Chor-Wing Sing, Ian C. K. Wong, Bernard M. Y. Cheung, Johnny C. Y. Chan, Jody K. P. Chu and Ching-Lung Cheung

    Version of Record online : 13 JAN 2017, DOI: 10.1002/pds.4156

  6. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

    Human Psychopharmacology: Clinical and Experimental

    Volume 21, Issue 6, August 2006, Pages: 387–391, Byung-Jo Kang, Man-Je Cho, Jung-Tae Oh, Yanghyun Lee, Beang-Jin Chae and Jaewook Ko

    Version of Record online : 19 JUL 2006, DOI: 10.1002/hup.779

  7. Drug-induced leukopenia and aplastic anemia

    Clinical Pharmacology & Therapeutics

    Volume 12, Issue 1, January 1971, Pages: 13–43, Anthony V. Pisciotta

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt197112113

  8. Agranulocytosis with Ceftaroline High-Dose Monotherapy or Combination Therapy with Clindamycin

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 6, June 2015, Pages: 608–612, Neilmegh L. Varada, George Sakoulas, Lani R. Lei and Jimmy Chua

    Version of Record online : 3 JUN 2015, DOI: 10.1002/phar.1596

  9. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors

    The Journal of Clinical Pharmacology

    Volume 55, Issue 8, August 2015, Pages: 920–925, Sheima Farag, Arjan J. Verschoor, Jacob W. Bosma, Hans Gelderblom, J. Martijn Kerst, Stefan Sleijfer and Neeltje Steeghs

    Version of Record online : 6 MAY 2015, DOI: 10.1002/jcph.498

  10. You have free access to this content
    Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974–1994)

    American Journal of Hematology

    Volume 57, Issue 3, March 1998, Pages: 206–211, M.M. van der Klauw, J.H.P. Wilson and B.H.Ch. Stricker

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1096-8652(199803)57:3<206::AID-AJH4>3.0.CO;2-Z

  11. The cytotoxicity of clozapine metabolites: Implications for predicting clozapine-induced agranulocytosis

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 5, May 1999, Pages: 526–532, Alice C. Tschen, Michael J. Rieder, L. Kola Oyewumi and David J. Freeman

    Version of Record online : 13 MAY 1999, DOI: 10.1016/S0009-9236(99)70072-X

  12. DRUG-INDUCED AGRANULOCYTOSIS, WITH SPECIAL REFERENCE TO AMINOPHENAZONE

    Acta Medica Scandinavica

    Volume 187, Issue 1-6, January/December 1970, Pages: 109–115, I. P. Palva and O. O. Mustala

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.0954-6820.1970.tb02916.x

  13. Reactive metabolites and agranulocytosis

    European Journal of Haematology

    Volume 57, Issue S60, December 1996, Pages: 83–88, Dr. Jack P. Uetrecht

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1996.tb01651.x

  14. HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

    European Journal of Immunogenetics

    Volume 25, Issue 1, February 1998, Pages: 11–13, A. Valevski, T. Klein, E. Gazit, S. Meged, D. Stein, A. Elizur, E.R. Narinsky, D. Kutzuk and A. Weizman

    Version of Record online : 27 FEB 2002, DOI: 10.1046/j.1365-2370.1998.00091.x

  15. HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis

    Clinical Pharmacology & Therapeutics

    Volume 99, Issue 5, May 2016, Pages: 555–561, C-L Cheung, C-W Sing, CSM Tang, VKF Cheng, M Pirmohamed, C-H Choi, C-S Hung, EY-F Lau, KF Lee, MW-H Mak, JYY Leung, T-W Wong, AYY Ho, K-W Chan, VHF Hung, V Tam, S-C Siu, H-K Pang, WZ-M Wat, HH-Y Lee, C-T Chung, RS-M Hue, P-C Sham, BMY Cheung, ICK Wong, KCB Tan and AWC Kung

    Version of Record online : 12 JAN 2016, DOI: 10.1002/cpt.309

  16. Drugs in the aetiology of agranulocytosis and aplastic anaemia

    European Journal of Haematology

    Volume 57, Issue S60, December 1996, Pages: 23–30, Dr. David W. Kaufman, Judith P. Kelly, Jan M. Jurgelon, Theresa Anderson, Surapol Issaragrisil, Bengt-Erik Wiholm, Neal S. Young, Paul Leaverton, Micha Levy and Samuel Shapiro

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1996.tb01641.x

  17. You have free access to this content
    Neutropenia and agranulocytosis in England and Wales: Incidence and risk factors

    American Journal of Hematology

    Volume 72, Issue 4, April 2003, Pages: 248–254, T.P. van Staa, F. Boulton, C. Cooper, A. Hagenbeek, H. Inskip and H.G.M. Leufkens

    Version of Record online : 21 MAR 2003, DOI: 10.1002/ajh.10295

  18. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study

    Clinical Pharmacology & Therapeutics

    Volume 49, Issue 3, March 1991, Pages: 330–341, Judith P Kelly, David W Kaufman and Samuel Shapiro

    Version of Record online : 10 MAR 1991, DOI: 10.1038/clpt.1991.37

  19. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis

    Pharmacoepidemiology and Drug Safety

    Volume 11, Issue 3, April/May 2002, Pages: 239–245, M. Bäckström, S. Hägg, T. Mjörndal and R. Dahlqvist

    Version of Record online : 3 MAY 2002, DOI: 10.1002/pds.697

  20. Procainamide-induced agranulocytosis with reversible myeloid sensitivity

    American Journal of Hematology

    Volume 17, Issue 4, December 1984, Pages: 427–432, John C. Nelson, John D. Lutton and Arthur E. Fass

    Version of Record online : 11 JUL 2006, DOI: 10.1002/ajh.2830170413